Helicobacter pylori (H. pylori), which is found in the stomach of approximately 50% of humans, remains there for almost the entire lifetime of the infected individual, leading to various gastrointestinal tract-associated disorders following full-blown infection. Due to the emergence of antibiotic resistance, recurrence and high cost of therapy, most antibiotic-based treatment strategies are not very effective in eradicating H. pylori infections. The quest for an alternative treatment free of these inconveniences is currently in demand. One of the important alternatives is propolis, produced by the honeybee Apis mellifera, which has been used to treat different diseases since it possesses a wide range of biochemical properties. Propolis has been reported as a useful therapeutic regimen against H. pylori, which is an important cause of gastric inflammation, peptic ulcer, gastric cancer, and lymphomas of mucosa-associated lymphoid tissues. Apart from propolis, various active compounds of other natural products have also been confirmed to be effective. This review compiles the scientific evidence of the role of propolis and other natural products against H. pylori-associated gastrointestinal tract-related health complexities by acing as an anti-angiogenic, anti-inflammatory, and antioxidant factor as well as via modulation of enzymatic activities.

Jahangirnagar University Department of Biochemistry and Molecular Biology Laboratory of Preventive and Integrative Biomedicine Savar Dhaka Bangladesh

Primeasia University Department of Biochemistry Banani Dhaka Bangla

Universiti Sains Malaysia School of Medical Sciences Human Genome Centre Kubang Kerian Kelantan Malaysia

Literatura

000      

00000naa a2200000 a 4500

001      

bmc18023517

003      

CZ-PrNML

005      

20190113114439.0

007      

ta

008      

180703s2018 xr d f 000 0|eng||

009      

AR

024    7_

$a 10.1016/j.jab.2017.10.007 $2 doi

040    __

$a ABA008 $d ABA008 $e AACR2 $b cze

041    0_

$a eng

044    __

$a xr

100    1_

$a Shapla, Ummay Mahfuza $u Jahangirnagar University, Department of Biochemistry and Molecular Biology, Laboratory of Preventive and Integrative Biomedicine, Savar, Dhaka, Bangladesh

245    10

$a Propolis: The future therapy against Helicobacter pylori-mediated gastrointestinal diseases / $c Ummay Mahfuza Shapla, Jinat Raihan, Asiful Islam, Fahmida Alam, Naeem Solayman, Siew Hua Gan, Sakib Hossen, Ibrahim Khalil

504    __

$a Literatura

520    9_

$a Helicobacter pylori (H. pylori), which is found in the stomach of approximately 50% of humans, remains there for almost the entire lifetime of the infected individual, leading to various gastrointestinal tract-associated disorders following full-blown infection. Due to the emergence of antibiotic resistance, recurrence and high cost of therapy, most antibiotic-based treatment strategies are not very effective in eradicating H. pylori infections. The quest for an alternative treatment free of these inconveniences is currently in demand. One of the important alternatives is propolis, produced by the honeybee Apis mellifera, which has been used to treat different diseases since it possesses a wide range of biochemical properties. Propolis has been reported as a useful therapeutic regimen against H. pylori, which is an important cause of gastric inflammation, peptic ulcer, gastric cancer, and lymphomas of mucosa-associated lymphoid tissues. Apart from propolis, various active compounds of other natural products have also been confirmed to be effective. This review compiles the scientific evidence of the role of propolis and other natural products against H. pylori-associated gastrointestinal tract-related health complexities by acing as an anti-angiogenic, anti-inflammatory, and antioxidant factor as well as via modulation of enzymatic activities.

650    12

$a propolis $x farmakokinetika $x terapeutické užití $7 D011429

650    12

$a rostlinné extrakty $x terapeutické užití $7 D010936

650    12

$a infekce vyvolané Helicobacter pylori $x diagnóza $x etiologie $x farmakoterapie $x imunologie $x komplikace $7 D016481

650    _2

$a Helicobacter pylori $x patogenita $x účinky léků $7 D016480

650    _2

$a gastritida $x etiologie $7 D005756

650    _2

$a peptický vřed $x etiologie $7 D010437

650    _2

$a nádory žaludku $x etiologie $7 D013274

650    _2

$a lymfom z B-buněk marginální zóny $x etiologie $7 D018442

650    _2

$a antiflogistika $7 D000893

650    _2

$a žaludeční sliznice $x patologie $7 D005753

650    _2

$a kombinovaná farmakoterapie $7 D004359

650    _2

$a bakteriální léková rezistence $7 D024881

650    _2

$a antibakteriální látky $x škodlivé účinky $x terapeutické užití $7 D000900

650    _2

$a klarithromycin $x terapeutické užití $7 D017291

650    _2

$a amoxicilin $x terapeutické užití $7 D000658

650    _2

$a metronidazol $x terapeutické užití $7 D008795

650    _2

$a inhibitory protonové pumpy $x terapeutické užití $7 D054328

650    _2

$a lidé $7 D006801

655    _2

$a přehledy $7 D016454

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Raihan, Jinat $u Jahangirnagar University, Department of Biochemistry and Molecular Biology, Laboratory of Preventive and Integrative Biomedicine, Savar, Dhaka, Bangladesh

700    1_

$a Islam, Asiful $u Universiti Sains Malaysia, School of Medical Sciences, Human Genome Centre, Kubang Kerian, Kelantan, Malaysia

700    1_

$a Alam, Fahmida $u Universiti Sains Malaysia, School of Medical Sciences, Human Genome Centre, Kubang Kerian, Kelantan, Malaysia

700    1_

$a Solayman, Naeem $u Jahangirnagar University, Department of Biochemistry and Molecular Biology, Laboratory of Preventive and Integrative Biomedicine, Savar, Dhaka, Bangladesh; Primeasia University, Department of Biochemistry, Banani, Dhaka, Bangla

700    1_

$a Gan, Siew Hua $u Universiti Sains Malaysia, School of Medical Sciences, Human Genome Centre, Kubang Kerian, Kelantan, Malaysia

700    1_

$a Hossen, Sakib $u Jahangirnagar University, Department of Biochemistry and Molecular Biology, Laboratory of Preventive and Integrative Biomedicine, Savar, Dhaka, Bangladesh; Primeasia University, Department of Biochemistry, Banani, Dhaka, Bangla

700    1_

$a Khalil, Ibrahim $u Jahangirnagar University, Department of Biochemistry and Molecular Biology, Laboratory of Preventive and Integrative Biomedicine, Savar, Dhaka, Bangladesh; Universiti Sains Malaysia, School of Medical Sciences, Human Genome Centre, Kubang Kerian, Kelantan, Malaysia

773    0_

$t Journal of applied biomedicine $x 1214-021X $g Roč. 16, č. 2 (2018), s. 81-99 $w MED00012667

856    41

$u https://jab.zsf.jcu.cz/pdfs/jab/2018/02/01.pdf $y plný text volně přístupný

910    __

$a ABA008 $b B 2301 $c 1249 $y 4 $z 0

990    __

$a 20180703055007 $b ABA008

991    __

$a 20190113114649 $b ABA008

999    __

$a ok $b bmc $g 1314614 $s 1020428

BAS    __

$a 3

BMC    __

$a 2018 $b 16 $c 2 $d 81-99 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667

LZP    __

$c NLK197 $d 20190113 $a NLK 2018-35/vt